SCHOLARSHIP

    1. Abstracts submitted by August 30, 2018 will be considered for a scholarship award. Three separate scholarship mechanisms will be offered to all meeting participants who meet the scholarship criteria outlined below. Abstracts will be scored and ranked by a blinded panel comprised of the participating faculty members and 2 participants from the meeting sponsor, Abiomed. The abstracts will be graded on a 1-10 point system (10 being the highest score) in each of the following categories: scientific merit, scientific originality, clarity and efficacy of presentation, and overall alignment with the meeting goals. The score of each category will be added together with a maximum score of 40 from an individual reviewer. Scores from all reviewers will be totaled, and the final score for the abstract will be calculated as the average score of all reviewers. Scores from all abstracts will then be ranked against all other abstracts according to their average score. In addition to the criteria for each scholarship mechanism (see below), in order to be considered for a scholarship each participant must meet the following criteria:
      1. The individual must attend the A-CURE Public Symposium on November 9, 2018, in Chicago, Illinois; under no circumstances will be the award be given to an attendee who does not attend the A-CURE Public Symposium.
      2. The individual must present the data submitted in the abstract at the A-CURE Public Symposium.
      3. If the scholarship awardee is unable to attend the A-CURE Public Symposium, the award will be forfeit, and the next highest score will be awarded the scholarship.
      4. The honoraria will be awarded in the form a check at the A-CURE Public Symposium.
      5. Travel arrangements are to be made through the appropriate Abiomed associate.
    2. Young Investigator Scholarship (Travel expenses to attend A-CURE Public Symposium plus a US$2,000 honoraria). The Young Investigator Scholarship will be awarded to the highest ranked abstract submitted by an investigator who is within 8 years of their terminal advanced degree or those enrolled in a program pursuant of such a degree (MD, PhD, MPH, etc.). The scholarship will cover travel expenses, up to US$3,000, associated with attending the A-CURE Public Symposium (limitations apply). An honoraria in the form of check valued at US$2,000 will also be awarded beyond the travel expenses.The awardee will be asked to give a 10 minute talk on their work at the A-CURE Public Symposium. At the time of submission please check the appropriate box to confirm entry into the Young Investigator Scholarship competition. In addition to those listed in section I. above, investigators who intend to compete for the The Young Investigator Scholarship must meet all the following criteria:
      1. Must be within 8 years of the issuance of their terminal advanced degree (MD, PhD, MPH, etc.) or be currently enrolled as a graduate or professional student in pursuit of such a degree.
      2. Must be either first or senior author on the submitted work.
      3. At the time of abstract submission, the date the terminal degree was conferred or the expected conference date must be supplied.
    3. Best in Research Scholarship (Travel expenses to attend A-CURE Public Symposium plus a US$2,000 honoraria).The Best in Research Scholarship will be awarded to the highest ranked abstract from all abstract submissions. The Best in Research Scholarship will cover travel expenses, up to US$3,000) associated with attending the A-CURE Public Symposium (limitations apply). An honoraria in the form of a check valued at US$2,000 will also be awarded beyond the travel expenses. All abstracts submitted by the August 30, 2018 deadline will automatically be considered for the scholarship. The awardee will be expected to give a 10 minute talk on their work at the A-CURE Public Symposium. To be considered for the award, the awardee must meet all the following criteria in addition to those listed in section I. above:
      1. The awardee of the Best in Research cannot also be the recipient of the Young Investigator Scholarship.
        1. In the case of both scholarship mechanisms identifying the same abstract for the award, the Best in Research Scholarship will then be awarded to the 2nd highest ranked overall abstract.
        2. Travel arrangements are to be made through the appropriate Abiomed associate.
    4. Research Merit Scholarship (Eight total scholarships covering travel expenses to and from the A-CURE Public Symposium).Eight (8) Research Merit Scholarships will be award to the next eight highest ranked abstracts submitted that were not awarded either the Young Investigator Scholarship or the Research Merit Scholarship. All abstracts submitted by the August 30, 2018 deadline and that meet the criteria of Section I. above will be automatically considered for the award.This scholarship will cover travel expenses, up to US$3,000, associated with attending the A-CURE Public Symposium (limitations apply).

 

Sunshine Act Compliance

This activity is not CME-accredited and therefore the sponsor (Abiomed, Inc) is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfer of value to US licensed physicians including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the support of this program. The information provided will be used for reporting purposes only.

Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.

No payments, referenced above, which are made in connection with the A-CURE Symposium are in return for the referral of ongoing business, if any, or in return for the purchasing, leasing, or ordering of any services or to induce or be contingent upon, the admission, recommendation or referral of any patient, directly or indirectly, and further, are not determined in any manner that takes into account the volume or value of other business generated between the physician and Abiomed, Inc.